BACKGROUND: Sleep disturbances have a major influence on quality of life. A commonly used measure of sleep disturbances is sleep efficiency. The purpose of this study was to investigate the prevalence of decreased subjective sleep efficiency in hemodialysis patients. An additional goal was to identify clinical, dialysis or laboratory parameters that are independently associated with decreased sleep efficiency. METHODS: Adult stable hemodialysis patients (n = 112) filled out a sleep questionnaire during a three day investigation period. In addition, healthy control subjects (n = 44) filled out the same questionnaire. From this questionnaire sleep efficiency (ratio of total sleep time to time spent in bed) was derived as a measure for sleep disturbances in this population. Laboratory, demographic and dialysis data were collected during the investigation period. For statistical analysis linear regression models were used. RESULTS: Median subjective sleep efficiency in hemodialysis patients was 80%, which was significantly less compared to the median subjective sleep efficiency of control subjects of 88% (p pound 0.05). Approximately 40% of the patients used sleep medication. However, less than 20% of them indicated improved sleep behavior when using these drugs. Elevated levels of phosphate and urea correlated independently with impaired sleep efficiency. Hemoglobin levels between 10 and 12 g/dl were associated with better sleep efficiency. CONCLUSION: In conclusion, decreased sleep efficiency was frequently reported in hemodialysis patients and can be associated with biochemical parameters. Hemoglobin, phosphate and urea levels can affect subjective sleep efficiency.
BACKGROUND:Sleep disturbances have a major influence on quality of life. A commonly used measure of sleep disturbances is sleep efficiency. The purpose of this study was to investigate the prevalence of decreased subjective sleep efficiency in hemodialysis patients. An additional goal was to identify clinical, dialysis or laboratory parameters that are independently associated with decreased sleep efficiency. METHODS: Adult stable hemodialysis patients (n = 112) filled out a sleep questionnaire during a three day investigation period. In addition, healthy control subjects (n = 44) filled out the same questionnaire. From this questionnaire sleep efficiency (ratio of total sleep time to time spent in bed) was derived as a measure for sleep disturbances in this population. Laboratory, demographic and dialysis data were collected during the investigation period. For statistical analysis linear regression models were used. RESULTS: Median subjective sleep efficiency in hemodialysis patients was 80%, which was significantly less compared to the median subjective sleep efficiency of control subjects of 88% (p pound 0.05). Approximately 40% of the patients used sleep medication. However, less than 20% of them indicated improved sleep behavior when using these drugs. Elevated levels of phosphate and urea correlated independently with impaired sleep efficiency. Hemoglobin levels between 10 and 12 g/dl were associated with better sleep efficiency. CONCLUSION: In conclusion, decreased sleep efficiency was frequently reported in hemodialysis patients and can be associated with biochemical parameters. Hemoglobin, phosphate and urea levels can affect subjective sleep efficiency.
Authors: Marije Russcher; Birgit C P Koch; J Elsbeth Nagtegaal; Frans J van Ittersum; Pieternel C M Pasker-de Jong; E Chris Hagen; Wim Th van Dorp; Bas Gabreëls; Thierry X Wildbergh; Monique M L van der Westerlaken; Carlo A J M Gaillard; Piet M Ter Wee Journal: Br J Clin Pharmacol Date: 2013-11 Impact factor: 4.335
Authors: Mark Unruh; Manjula Kurella Tamura; Brett Larive; Anjay Rastogi; Sam James; Brigitte Schiller; Jennifer Gassman; Christopher Chan; Robert Lockridge; Alan Kliger Journal: Am J Nephrol Date: 2011-04-08 Impact factor: 3.754
Authors: Birgit C P Koch; J Elsbeth Nagtegaal; E Chris Hagen; Monique M L van der Westerlaken; Jan B S Boringa; Gerard A Kerkhof; Piet M Ter Wee Journal: Br J Clin Pharmacol Date: 2008-11-17 Impact factor: 4.335
Authors: Kunyu Shen; Yeoungjee Cho; Elaine M Pascoe; Carmel M Hawley; Veronica Oliver; Kathryn M Hughes; Richard Baer; Jeremy Frazier; Elizabeth Jarvis; Ken-Soon Tan; Xusheng Liu; Glenda Gobe; David W Johnson Journal: Evid Based Complement Alternat Med Date: 2017-02-21 Impact factor: 2.629
Authors: Inayat Ur Rehman; David Bin-Chia Wu; Raheel Ahmed; Nisar Ahmad Khan; Aziz Ur Rahman; Syed Munib; Learn Han Lee; Kok Gan Chan; Tahir Mehmood Khan Journal: Medicine (Baltimore) Date: 2018-08 Impact factor: 1.817